The implantable cardioverter defibrillator (ICD) represented a breakthrough in the prevention of sudden cardiac death. In addition to its use in secondary prevention, the indication of ICD therapy in primary prevention is also being intensively researched. A study published last year evaluated the relevance of ICD implantation in the acute phase of acute myocarditis and a registry study investigated the benefits of a wearable cardioverter defibrillator (WCD) for the prevention of sudden cardiac death in post-infarction patients.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Patient-centered rounds in medicine
Aligning care with the patient
- Adrenogenital syndrome
Clinical care from birth to adulthood
- Communication between hospitals and outpatient care
How does a digital clinical information system prove itself in everyday practice?
- Acute myeloid leukemia
Treatment decisions between MRD monitoring, transplantation and CAR-T cells
- Psoriasis and metabolic comorbidities: new study data
GLP-1RAs showed a valuable dual benefit
- Heart failure: combination of four as "Guideline-Directed Medical Therapy"
Standard established at HFrEF with individual nuances
- Chronic inflammation as a driver of ageing
Immunosenescence and inflammaging
- Evidence, limitations and practical implications